E. Blanco-Reina

发表

Assessment of off-label prescribing: profile, evidence and evolution.

R. Ocaña-Riola, E. Blanco-Reina, Azucena Muñoz-García, 2017, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Assessing Potentially Inappropriate Prescribing in Community-Dwelling Older Patients Using the Updated Version of STOPP-START Criteria: A Comparison of Profiles and Prevalences with Respect to the Original Version

R. Ocaña-Riola, E. Blanco-Reina, María Rosa García-Merino, 2016, PloS one.

Prevalence and Clinical Conditions Related to Sarcopaenia among Older Persons Living in the Community

R. Ocaña-Riola, E. Blanco-Reina, María Rosa García-Merino, 2022, Journal of clinical medicine.

Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids

C. Stephens, R. Andrade, M. Lucena, 2015, Alimentary pharmacology & therapeutics.

Drug utilization pattern in children and off-label use of medicines in a pediatric intensive care unit.

R. Ocaña-Riola, Á. Ruiz-Extremera, E. Blanco-Reina, 2016, Medicina intensiva.

Herbal and Dietary Supplement‐Induced Liver Injuries in the Spanish DILI Registry

C. Stephens, R. Andrade, M. L. de la Mata, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Age-period-cohort effects on mortality from cerebrovascular disease in southern Spain.

R. Ocaña-Riola, J. Mayoral-Cortés, E. Blanco-Reina, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Factors Associated with Health-Related Quality of Life in Community-Dwelling Older Adults: A Multinomial Logistic Analysis

R. Ocaña-Riola, E. Blanco-Reina, María Rosa García-Merino, 2019, Journal of clinical medicine.

Age–period–cohort effect on lung cancer mortality in southern Spain

R. Ocaña-Riola, J. Mayoral-Cortés, E. Blanco-Reina, 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

R. Ocaña-Riola, E. Blanco-Reina, I. Bellido-Estévez, 2014, European Journal of Clinical Pharmacology.

2012 American Geriatrics Society Beers Criteria: Enhanced Applicability for Detecting Potentially Inappropriate Medications in European Older Adults? A Comparison with the Screening Tool of Older Person's Potentially Inappropriate Prescriptions

R. Ocaña-Riola, E. Blanco-Reina, Gabriel Ariza-Zafra, 2014, Journal of the American Geriatrics Society.

Level of Palliative Care Complexity in Advanced Cancer Patients: A Multinomial Logistic Analysis

R. Ocaña-Riola, E. Blanco-Reina, Rafael Gómez-García, 2020, Journal of clinical medicine.

Age, Period, and Cohort Effects on Mortality From Ischemic Heart Disease in Southern Spain.

P. Martín-Olmedo, R. Ocaña-Riola, J. Mayoral-Cortés, 2015, Revista espanola de cardiologia.

Assessing Prevalence and Factors Related to Frailty in Community-Dwelling Older Adults: A Multinomial Logistic Analysis

R. Ocaña-Riola, E. Blanco-Reina, María Rosa García-Merino, 2021, Journal of clinical medicine.

Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

R. Ocaña-Riola, E. Blanco-Reina, I. Bellido-Estévez, 2015, European Journal of Clinical Pharmacology.

2015 Beers Criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors

R. Ocaña-Riola, E. Blanco-Reina, María Rosa García-Merino, 2019, European Journal of Clinical Pharmacology.

2015 Beers Criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors

R. Ocaña-Riola, E. Blanco-Reina, María Rosa García-Merino, 2019, European Journal of Clinical Pharmacology.

Neuropeptide Y receptor 1 and galanin receptor 2 (NPY1R-GALR2) interactions in the dentate gyrus and their relevance for neurogenesis and cognition

D. Borroto-Escuela, M. Narváez, N. García-Casares, 2024, Frontiers in cellular neuroscience.

Effectiveness of Vortioxetine Treatment on Depression and Cognitive Functions in Patients with Alzheimer’s Disease: A 12-Month, Retrospective, Observational Study

M. Barbancho, J. M. García-Alberca, E. Blanco-Reina, 2024, Journal of Personalized Medicine.